IFIT1 and acute myeloid leukemia: IFIT1, IFIT2, IFIT3, and IFIT5 are overexpressed in acute myeloid leukemia (AML) patients, with higher levels of IFIT2, IFIT3, and IFIT5 predicting poor prognosis 51.